title: Free speech rights outweigh restrictions on promoting drugs off label, court rules.
authors.forename: Bob
authors.initials: B
authors.lastname: Roehr
mesh_terms: D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006806:Human Rights / Q000331:legislation & jurisprudence*; D006801:Humans; D040541:Marketing / Q000331:legislation & jurisprudence*; D009290:Narcolepsy / Q000188:drug therapy; D009518:New York; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000627:therapeutic use*; D012978:Sodium Oxybate / Q000627:therapeutic use; D035521:Supreme Court Decisions; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D055553:Prescription Drugs; D012978:Sodium Oxybate